Home Overview Press Room Blog Publications For Students about us
Search

Patents & Other IP : Displaying 208-217 of 332


Don't Bite the Hand that Feeds Youby Jesse ReynoldsBiopolitical TimesAugust 3rd, 2007Given the magnitude of Keirstead's promotional activities, his undisclosed personal financial interest, and his own statement of clinical trials "in about a year" back in 2002, his pronouncements on the timeline for embryonic stem cell trials should receive a great deal of skepticism.
Scientist seeks patent to life formby Kelly PattersonCheckbiotechJune 12th, 2007A leading U.S. scientist has applied to patent the world's first man-made life form.
Gene Patent Billby Osagie K. ObasogieBiopolitical TimesMay 18th, 2007The Genomic Research and Accessibility Act - aiming to curb the gold rush on patenting human genes - is making its way through Congress.
Federal Bill to Ban Patents on Human Genes IntroducedGenetic CrossroadsApril 30th, 2007The "Genomic Research and Accessibility Act" would prohibit future patents on human genes, a practice that has given "private corporations, universities, and even the federal government…a monopoly on significant sections of the human genome."
UK's HFEA Lowers the Bar, Againby Jesse ReynoldsBiopolitical TimesApril 30th, 2007The Human Fertilization and Embryology Authority - Britain's regulatory body for reproductive and genetic technologies - has just given the green light for IVF embryos to be screened for the "breast cancer genes." But besides this lowering of the bar in expanding PGD's use, this also highlights two roles played by government in promoting what some call a "new eugenics."
U.S. invalidates three human stem cell patentsby Karen KaplanLos Angeles TimesApril 4th, 2007The U.S. Patent and Trademark Office has invalidated three broad patents for human embryonic stem cells that have been blamed for slowing research in the highly visible field of regenerative medicine.
CGS letter on California's SB771April 4th, 2007CGS supports, if amended, SB771. We are concerned that the bill as currently written does not go far enough to protect Californians from potentially unfair pricing practices.
Restrictive Stem Cell Patents Overturnedby Jesse ReynoldsBiopolitical TimesApril 4th, 2007The licensing arm of the University of Wisconsin has long been criticized for its patents in embryonic stem cell research. Earlier this week, a federal agency agreed with these sentiments, and invalidated its stem cell patents.
Genetic justice, industry styleby Marcy DarnovskyBiopolitical TimesMarch 19th, 2007The issues raised by the intertwining of law and human biotechnologies are often technically and socially complex. What's a busy jurist to do?
Neurolawby Osagie K. ObasogieBiopolitical TimesMarch 13th, 2007Should courts be in the business of deciding when to mitigate someone's criminal responsibility because his brain functions improperly, whether because of age, in-born defects or trauma?
Displaying 208-217 of 332  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760